SYNMOSA BIOPHARMA CORP financial statements, including revenue, expenses, profit, and loss

The total revenue of 4114 for the last quarter is 1.42 B TWD, and it's 6.83% higher compared to the previous quarter. The net income of Q3 24 is 163.42 M TWD.